Morris Plains, NJ, United States of America

Gade Brahma Reddy

This inventor holds 1 USPTO granted patent. Top assignee: Diakron Pharmaceuticals, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gade Brahma Reddy. Retrieved from https://idiyas.com/inventor/gade-brahma-reddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gade Brahma Reddy: Innovator in Pharmaceutical Chemistry

Introduction

Gade Brahma Reddy is a notable inventor based in Morris Plains, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of thrombin inhibitors.

Latest Patents

Reddy holds a patent for a process titled "Process for the preparation of pyrazinone thrombin inhibitor and its intermediates." This patent describes an improved method for preparing a specific compound, 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide, along with its intermediates. He has 1 patent to his name, showcasing his innovative approach to drug development.

Career Highlights

Gade Brahma Reddy is currently employed at Diakron Pharmaceuticals, Inc., where he continues to work on advancing pharmaceutical technologies. His expertise in the preparation of complex chemical compounds has positioned him as a valuable asset in the industry.

Collaborations

Reddy collaborates with talented professionals in his field, including Reguri Buchi Reddy and Upparapalli Sampathkumar. These partnerships enhance the research and development efforts at Diakron Pharmaceuticals.

Conclusion

Gade Brahma Reddy's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key inventor in the industry. His work continues to influence the development of effective thrombin inhibitors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…